Can Treatment With Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

Trial Profile

Can Treatment With Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Tinzaparin sodium (Primary)
  • Indications Embolism and thrombosis; Fetal growth retardation
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2016 Status changed from recruiting to completed.
    • 18 May 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Aug 2016.
    • 08 Jun 2015 Planned End Date changed from 1 Nov 2013 to 1 Sep 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top